Anti-CD20 Antibody (Ocrelizumab)
Catalog No.
F1375
Anti-CD20 Antibody (Ocrelizumab)
Featured Products
Ocrelizumab (Ocrevus) is a humanized anti-CD20 monoclonal antibody that induces B cell depletion and inhibits multiple sclerosis lesions in mice via antibody-dependent cellular cytotoxicity (ADCC).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.82 kDa
Dry ice
637334-45-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
PRO70769, RG1594
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P11836
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human CD20 CHO-K1 cells were stained with Anti-CD20 Antibody (Ocrelizumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
CD20
Please avoid freeze-thaw cycles.